However, the results may vary according to the cancer type, for instance, some studies showed that low levels of MSH2 expression were associated with a high survival in non- small cell lung cancer and were not associated with a poor survival in ovarian cancer (39, 40). This evidence concerns the gene MSH2 and non-small cell lung carcinoma.